Compare H.M. Sampoerna Tbk. (HMSP) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
H.M. Sampoerna Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? H.M. Sampoerna Tbk. trades at Rp730 (market cap 86.08T, 6.17M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: H.M. Sampoerna Tbk. is far larger — about 824.5× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| HMSP | SCPI | |
|---|---|---|
Market Cap | 86.08T | 104.4B |
Volume | 6.17M | — |
Lot | 61.7K | — |
Turnover | 4.52B | — |
Average Price | 732.19 | — |
Value | 4.52B | — |
Indicative Equilibrium Price | 730 | — |
Indicative Equilibrium Volume | 3.68K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About H.M. Sampoerna Tbk.
PT Hanjaya Mandala Sampoerna Tbk (the Company) was established in Indonesia on October 19, 1963 based on Notarial Deed No. 69 of Anwar Mahajudin, S.H.. The Company started its commercial operation since 1913 in Surabaya, as a home industry. In 1930, this home industry was officially organized under the name of NVBM Handel Maatschapij Sampoerna.
Read more on HMSP →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
